Long-Covid-19 Alleviation Through Learning Mindfulness Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorColumbia University

About this trial

This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.

Eligibility criteria

Qualifiers

Age > or = 18

Willing and able to provide informed consent

Access to the internet

Self-reported history of SARS-CoV-2 infection

Disqualifiers

Participating in another clinical trial of an intervention for PASC symptoms

Engaged in a structured MBI

Trial design

Treatments tested in this trial

  • Structured mindfulness intervention

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators